M1 macrophage membrane-engineered PLGA nanoparticles reprogram M2 tumor-associated macrophages to enhance anti-tumor immunity in breast cancer.
Saved in:
| Title: | M1 macrophage membrane-engineered PLGA nanoparticles reprogram M2 tumor-associated macrophages to enhance anti-tumor immunity in breast cancer. |
|---|---|
| Authors: | Katebi A; Department of Immunology, Pasteur Institute of Iran, Tehran, Iran., Riazi-Rad F; Department of Immunology, Pasteur Institute of Iran, Tehran, Iran., Ahangari F; Department of Immunology, Pasteur Institute of Iran, Tehran, Iran., Ajdary S; Department of Immunology, Pasteur Institute of Iran, Tehran, Iran. sohary@yahoo.com. |
| Source: | Journal of materials science. Materials in medicine [J Mater Sci Mater Med] 2026 Feb 20; Vol. 37 (1). Date of Electronic Publication: 2026 Feb 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9013087 Publication Model: Electronic Cited Medium: Internet ISSN: 1573-4838 (Electronic) Linking ISSN: 09574530 NLM ISO Abbreviation: J Mater Sci Mater Med Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
